ClinicalTrials.Veeva

Menu

C1q/TNF-related Proteins in Non-Alcoholic Fatty Liver Disease

K

Korea University

Status

Unknown

Conditions

NAFLD

Study type

Observational

Funder types

Other

Identifiers

NCT02083159
NAFLD(CTRP)

Details and patient eligibility

About

Non-alcoholic fatty liver disease (NAFLD) is characterized by an accumulation of fat in the liver, which is one of the most common forms of chronic liver disease in developed countries. In western countries, the prevalence of NAFLD in the general population is estimated to be 20-30%; in obese populations, this increases to 57.5-74%. But, it hasn't been clearly elucidated yet regarding the underlying disease pathophysiology and treatmet strategy.

Recently, members of the C1q/tumor necrosis factor-related protein (CTRP) family have been reported to share structural homology with adiponectin. To date, 15 CTRP family members have been found that might play major roles in glucose metabolism and inflammation.

The investigators tried to clarify the relationship between CTRP family and NAFLD in Korean men and women.

Enrollment

500 estimated patients

Sex

All

Ages

20 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • 20<age<80
  • apparently healthy subjects

Exclusion criteria

  • a history of CVD
  • diabetes
  • stage 2 hypertension
  • malignancy
  • severe renal or hepatic disease

Trial design

500 participants in 1 patient group

Patients with NAFLD

Trial contacts and locations

1

Loading...

Central trial contact

Ho Cheol Hong, M.D.; Kyung Mook Choi, M.D.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems